Characteristics | Relative Risk for Deaths Among General | Relative risk of death among the severely ill |
Sex Male Female |
2.5 0.4 |
1.1 0.9 |
Age Group Under 50 years old 50 - 59 years old 60 years or older <60 years old ≥60 years old 50 - 59 years old >60 years old Under 50 years old ≥60 years old Under 50 years old 50 - 59 years old |
0.3 0.5 3.6 0.2 3.6 0.3 2.9 0.2 4.1 0.2 4.1 |
0.9 0.9 1.1 0.9 1.1 0.9 1.1 0.9 1.1 1 1 |
District of Residence Água Grande Mezochi Cantagalo Lobata |
0.8 1.6 1.6 0 |
1 1.3 1.2 0 |
Vaccination status Vaccinated 1 dose Not vaccinated Vaccinated 2 doses Not vaccinated 2 vaccine doses or single dose 1 vaccine dose |
0.5 1.9 |
0.4 0.2 |
N˚ of Comorbidities |
|
|
N˚ of Comorbidities: No comorbidity With comorbidities 1 comorbidity More than 1 comorbidity No comorbidities 2 comorbidities No comorbidities 3 or 4 comorbidities |
0.1 8 0.3 2.9 0.09 10 0.03 33.3 |
0.4 2.4 0.5 1.7 0.3 2.8 0.25 4 |
Comorbities | RR for death among hospitalists | RR for death among the severely ill |
Cardiovascular Diseases (CVD) | 0.8 | 0.9 |
Diabetes mellitus | 1.4 | 1.5 |
Asthma/COPD | 0 | 0 |
HIV | 0 | 0 |
Dementia | 2.6 | 1.4 |
Neoplasia | 2.6 | 1.4 |
Testicular infection-surgery | 2.6 | 1.4 |
Psychiatric disorder | 0.4 | 1.4 |
Obesity | 1.9 | 1.1 |
Alcoholism | 0 | 0 |
Antibiotics |
|
|
Ceftriaxone Cefotaxime Azithromycin/erythromycin Amoxicillin/clavulonate | 1.9 0.2 0.9 0.2 | 1 1 1 1 |
Thrombolytic/anticoagulant |
|
|
Enoxaparin | - | 0.6 |
Without enoxaparin | - | 1.3 |
Corticoids |
|
|
Dexamethasone | - | 0.3 |
Without Dexamethasone | - | 3.3 |